186 related articles for article (PubMed ID: 23860667)
1. Serum S100B protein could help to detect cerebral complications associated with extracorporeal membrane oxygenation (ECMO).
Nguyen DN; Huyghens L; Wellens F; Schiettecatte J; Smitz J; Vincent JL
Neurocrit Care; 2014 Jun; 20(3):367-74. PubMed ID: 23860667
[TBL] [Abstract][Full Text] [Related]
2. A Pilot Study of the Use of Dexmedetomidine for the Control of Delirium by Reducing the Serum Concentrations of Brain-Derived Neurotrophic Factor, Neuron-Specific Enolase, and S100B in Polytrauma Patients.
Li Y; Yu ZX; Ji MS; Yan J; Cai Y; Liu J; Yang HF; Jin ZC
J Intensive Care Med; 2019 Aug; 34(8):674-681. PubMed ID: 28569132
[TBL] [Abstract][Full Text] [Related]
3. Elevated S100B protein as an early indicator of intracranial haemorrhage in infants subjected to extracorporeal membrane oxygenation.
Gazzolo D; Masetti P; Meli M; Grutzfeld D; Michetti F
Acta Paediatr; 2002; 91(2):218-21. PubMed ID: 11952012
[TBL] [Abstract][Full Text] [Related]
4. Neurological injury after extracorporeal membrane oxygenation use to aid pediatric cardiopulmonary resuscitation.
Barrett CS; Bratton SL; Salvin JW; Laussen PC; Rycus PT; Thiagarajan RR
Pediatr Crit Care Med; 2009 Jul; 10(4):445-51. PubMed ID: 19451851
[TBL] [Abstract][Full Text] [Related]
5. Safety research of extracorporeal membrane oxygenation treatment on cardiogenic shock: a multicenter clinical study.
Hou G; Yu K; Yin X; Wang H; Xu W; Du Z; Hou X; Long Y; Chen H; Xu L; Liu S
Minerva Cardioangiol; 2016 Apr; 64(2):121-6. PubMed ID: 26080684
[TBL] [Abstract][Full Text] [Related]
6. Outcome of patients with profound cardiogenic shock after cardiopulmonary resuscitation and prompt extracorporeal membrane oxygenation support. A single-center observational study.
Chung SY; Sheu JJ; Lin YJ; Sun CK; Chang LT; Chen YL; Tsai TH; Chen CJ; Yang CH; Hang CL; Leu S; Wu CJ; Lee FY; Yip HK
Circ J; 2012; 76(6):1385-92. PubMed ID: 22447007
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Factors for Survival After Extracorporeal Membrane Oxygenation for Cardiogenic Shock.
Huang M; Ong BH; Hoo AEE; Gao F; Chao VTT; Lim CH; Tan TE; Sin KYK
ASAIO J; 2020 Feb; 66(2):141-145. PubMed ID: 30864968
[TBL] [Abstract][Full Text] [Related]
8. Extracorporeal life support for adults with refractory septic shock.
Ro SK; Kim WK; Lim JY; Yoo JS; Hong SB; Kim JB
J Thorac Cardiovasc Surg; 2018 Sep; 156(3):1104-1109.e1. PubMed ID: 29753504
[TBL] [Abstract][Full Text] [Related]
9. Clinical risk factors of extracorporeal membrane oxygenation support in older adults.
Yeh TC; Chang HH; Ger LP; Wang JO; Kao S; Ho ST
PLoS One; 2018; 13(4):e0195445. PubMed ID: 29624620
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes in patients after extracorporeal membrane oxygenation support for post-cardiotomy cardiogenic shock: a single-centre experience of 92 cases.
Guihaire J; Dang Van S; Rouze S; Rosier S; Roisne A; Langanay T; Corbineau H; Verhoye JP; Flécher E
Interact Cardiovasc Thorac Surg; 2017 Sep; 25(3):363-369. PubMed ID: 28575211
[TBL] [Abstract][Full Text] [Related]
11. Protocol for a multicentre randomised controlled trial evaluating the effects of moderate hypothermia versus normothermia on mortality in patients with refractory cardiogenic shock rescued by venoarterial extracorporeal membrane oxygenation (VA-ECMO) (HYPO-ECMO study).
Jacquot A; Lepage X; Merckle L; Girerd N; Levy B
BMJ Open; 2019 Oct; 9(10):e031697. PubMed ID: 31615800
[TBL] [Abstract][Full Text] [Related]
12. The dynamic change of serum S100B levels from day 1 to day 3 is more associated with sepsis-associated encephalopathy.
Wu L; Feng Q; Ai ML; Deng SY; Liu ZY; Huang L; Ai YH; Zhang L
Sci Rep; 2020 May; 10(1):7718. PubMed ID: 32382007
[TBL] [Abstract][Full Text] [Related]
13. Serial S100B Sampling Detects Intracranial Lesion Development in Patients on Extracorporeal Membrane Oxygenation.
Fletcher-Sandersjöö A; Lindblad C; Thelin EP; Bartek J; Sallisalmi M; Elmi-Terander A; Svensson M; Bellander BM; Broman LM
Front Neurol; 2019; 10():512. PubMed ID: 31156541
[No Abstract] [Full Text] [Related]
14. The biomarkers neuron-specific enolase and S100b measured the day following admission for severe accidental hypothermia have high predictive values for poor outcome.
Wiberg S; Kjaergaard J; Kjærgaard B; Møller B; Nørnberg B; Sørensen AM; Hassager C; Wanscher M
Resuscitation; 2017 Dec; 121():49-53. PubMed ID: 29017847
[TBL] [Abstract][Full Text] [Related]
15. Device Strategies for Patients in INTERMACS Profiles 1 and 2 Cardiogenic Shock: Double Bridge With Extracorporeal Membrane Oxygenation and Initial Implant of More Durable Devices.
Cheng R; Ramzy D; Azarbal B; Arabia FA; Esmailian F; Czer LS; Kobashigawa JA; Moriguchi JD
Artif Organs; 2017 Mar; 41(3):224-232. PubMed ID: 27658844
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of venoarterial-extracorporeal membrane oxygenation (VA-ECMO) in patients with drug-induced cardiogenic shock: a retrospective study of the Extracorporeal Life Support Organizations' ECMO case registry.
Weiner L; Mazzeffi MA; Hines EQ; Gordon D; Herr DL; Kim HK
Clin Toxicol (Phila); 2020 Jul; 58(7):705-710. PubMed ID: 31617764
[No Abstract] [Full Text] [Related]
17. Weaning adult patients with cardiogenic shock on veno-arterial extracorporeal membrane oxygenation by pump-controlled retrograde trial off.
Ling L; Chan KM
Perfusion; 2018 Jul; 33(5):339-345. PubMed ID: 29409389
[TBL] [Abstract][Full Text] [Related]
18. Blood Lactate as a Reliable Marker for Mortality of Pediatric Refractory Cardiogenic Shock Requiring Extracorporeal Membrane Oxygenation.
Yang L; Fan Y; Lin R; He W
Pediatr Cardiol; 2019 Mar; 40(3):602-609. PubMed ID: 30600369
[TBL] [Abstract][Full Text] [Related]
19. Transcranial Doppler is an effective method in assessing cerebral blood flow patterns during peripheral venoarterial extracorporeal membrane oxygenation.
Salna M; Ikegami H; Willey JZ; Garan AR; Cevasco M; Chan C; Takayama H; Colombo PC; Naka Y; Takeda K
J Card Surg; 2019 Jun; 34(6):447-452. PubMed ID: 31058374
[TBL] [Abstract][Full Text] [Related]
20. Initiation of Extracorporeal Membrane Oxygenation in the Cardiac Catheterization Laboratory: The Mayo Clinic Experience.
Ternus B; Jentzer J; Bohman K; Barsness G; Schears G; Rihal C; Sandhu G
J Invasive Cardiol; 2020 Feb; 32(2):64-69. PubMed ID: 31841997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
